Colon Cancer Evaluation and Staging

  • Eric G. Weiss


Colorectal cancer is the third most common cancer affecting persons in the USA. In 2008, there were an estimated 148,810 new cases of colon and rectal cancer with colon cancer making up the majority of new cases at 107,143 and the remaining 28% arising in the rectum.1 Overall, approximately 33.6% of newly diagnosed patients with colorectal cancer in the USA will die of their disease.


  1. 1.
    Colorectal Cancer Facts and Figures 2008–10. American Cancer Society.Google Scholar
  2. 2.
    Beart RW, Steele GD, Merck HR, et al. Management and survival of patients with adenocarcinoma of the colon and rectum; a national survey of the Commission on Cancer. J Am Coll Surg. 1995;181:225–36.PubMedGoogle Scholar
  3. 3.
    Ferraris R, Senore C, Fracchia M, et al. Predictive value of rectal bleeding for distal colonic neoplastic lesions in a screened population. Eur J Cancer. 2004;40:245–52.CrossRefGoogle Scholar
  4. 4.
    Helfand M, Marton KI, Zimmer-Gembeck MJ, et al. History of visible rectal bleeding in a primary care population: initial assessment and 10-year follow-up. JAMA. 1997;277:44–8.CrossRefGoogle Scholar
  5. 5.
    Lewis JD, Shih CE, Blecker D. Endoscopy for hematochezia in patients under 50 years of age. Dig Dis Sci. 2001;46:2660–5.CrossRefGoogle Scholar
  6. 6.
    Gilbertsen VA, Williams SE, Schuman L, et al. Paper presentation at the International Symposium on Colorectal Cancer, New York, March 1979.Google Scholar
  7. 7.
    Cole SR, Young GP, Esterman A, Cadd A, Morcom J. A randomised trial of the impact of new faecal haemoglobin test technologies on population participation in screening for colorectal cancer. J Med Screen. 2003;10:117–22.CrossRefGoogle Scholar
  8. 8.
    Corman ML, Veidenheimer MC, Coller JA. Colorectal carcinoma: a decade of experience at the Lahey Clinic. Dis Colon Rectum. 1979;22:477–9.CrossRefGoogle Scholar
  9. 9.
    Duke CE. The spread of cancer of the rectum. Br J Surg. 1930;17:643–8.CrossRefGoogle Scholar
  10. 10.
    Kirklin JW, Dockerty MB, Waugh JM. The role of retroperitoneal reflection in the prognosis of carcinoma of the rectum and sigmoid colon. Surg Gynecol Obstet. 1949;88:326–31.PubMedGoogle Scholar
  11. 11.
    Astler VB, Coller FA. Prognostic significance of direct extension of carcinoma of the colon and rectum. Ann Surg. 1954;139:846.CrossRefGoogle Scholar
  12. 12.
    Edge SB, Byrd DR, Compton CC, Fritz AG, Green FL, Trotti A. AJCC staging manual. 7th ed. New York: Springer; 2010.Google Scholar
  13. 13.
    Gunderson LL, Jessup JM, Sargent DJ, Greene FL, et al. Revised TN categorization for colon cancer based on national survival outcomes data. J Clin Oncol. 2009;28:264–71.CrossRefGoogle Scholar
  14. 14.
    O’Connell JB, Maggard MA, Liu JH, Etzioni DA, et al. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28:558–62.CrossRefGoogle Scholar
  15. 15.
    Chen HS, Sheen-Chen SM. Obstruction and perforation in colorectal adenocarcinoma: an analysis of prognosis and current trends. Surgery. 2000;127:370–6.CrossRefGoogle Scholar
  16. 16.
    Sibbering DM, Locker AP, Hardcastle JD, et al. Blood transfusion and survival in colorectal cancer. Dis Colon Rectum. 1994;37:358–63.CrossRefGoogle Scholar
  17. 17.
    Chung M, Steinmetz OK, Gordon PH. Perioperative blood transfusion and outcome after resection for colorectal carcinoma. Br J Surg. 1993;80:427–32.CrossRefGoogle Scholar
  18. 18.
    Kama NA, Reis E, Doganay M, et al. Radical surgery of colon cancers directly invading the duodenum, pancreas and liver. Hepatogastroenterology. 2001;48:114–7.PubMedGoogle Scholar
  19. 19.
    Izbicki JR, Hosch SB, Knoefel WT, et al. Extended resections are beneficial for patients with locally advanced colorectal cancer. Dis Colon Rectum. 1995;38:1251–6.CrossRefGoogle Scholar
  20. 20.
    Kroneman H, Castelein A, Jeekel J. En bloc resection of colon carcinoma adherent to other oragans: an efficacious treatment? Dis Colon Rectum. 1991;34:780–3.CrossRefGoogle Scholar
  21. 21.
    Cooper HS, Slemmer JR. Surgical pathology of carcinoma of the colon and rectum. Semin Oncol. 1991;18:367–80.PubMedGoogle Scholar
  22. 22.
    Morodomi T, Isomoto H, Shirouzo K, et al. An index for estimating the probability of lymph node metastases in rectal cancer. Lymph node metastasis and histopathology of actively invasive regions of cancer. Cancer. 1989;63(3): 539–43.CrossRefGoogle Scholar
  23. 23.
    Park K-J, Choi H-J, Roh M-S, et al. Intensity of tumor budding and its prognostic implications in invasive colon carcinoma. Dis Colon Retum. 2005;48(8):1597–602.CrossRefGoogle Scholar
  24. 24.
    Nakamura T, Mitomi H, Kikuchi S, et al. Evaluation of usefulness of tumor budding on the prediction of metastases to the lung and liver after curative excision of colorectal cancer. Hepatogastroenterology. 2005;52:1432–5.PubMedGoogle Scholar
  25. 25.
    Bittorf B, Merkel S, Matzel KE, et al. Primary signet-ring cell carcinoma of the colorectum. Langenbecks Arch Surg. 2004;389:178–83.CrossRefGoogle Scholar
  26. 26.
    Psathakis D, Schiedick TH, Krug F, et al. Ordinary colorectal adenocarcinoma vs primary colorectal signet-ring cell carcinoma: study matched for age, gender, grade and stage. Dis Colon Rectum. 1999;42:1618–25.CrossRefGoogle Scholar
  27. 27.
    Minsky BD, Mies C, Recht A, et al. Resectable adenocarcinoma of the rectosigmoid and rectum: II. The influence of blood vessel invasion. Cancer. 1988;61:1417–24.CrossRefGoogle Scholar
  28. 28.
    Knudsen JB, Nilsson T, Sprechler M, et al. Venous and nerve invasion as prognostic factors in postoperative survival of patients with respectable cancer of the rectum. Dis Colon Rectum. 1983;26:613–7.CrossRefGoogle Scholar
  29. 29.
    Compton CC. Pathology report in colon cancer: what is prognostically important. Dig Dis. 1999;17:67–79.CrossRefGoogle Scholar
  30. 30.
    Scott KW, Grace RH. Detection of lymph node metastases in colorectal carcinoma before and after fat clearance. Br J Surg. 1989;76:1165–7.CrossRefGoogle Scholar
  31. 31.
    Herrera L, Luna P, Villarreal JR. Lymph-node clearance techniques. Dis Colon Rectum. 1991;34:513–4.CrossRefGoogle Scholar
  32. 32.
    Koren R, Seigal A, Klein B, Halpern M, et al. Lymph node revealing solution: simple new method for detecting minute lymph nodes in colon cancer. Dis Colon Rectum. 1997;40:407–10.CrossRefGoogle Scholar
  33. 33.
    Gold P, Freedman SO. Demonstration of tumor-specific antigens in human colonic carcinomata by immunological tolerance and absorption techniques. J Exp Med. 1965;121:439.CrossRefGoogle Scholar
  34. 34.
    Rosenberg R, Friederichs J, Gertler R, et al. Prognostic evaluation and review of immunohistochemically detected disseminated tumor cells in peritumoral lymph nodes of patients with pNo colorectal cancer. Int J Colorectal Dis. 2004;19(5):430–7.CrossRefGoogle Scholar
  35. 35.
    Wiratkapun S, Kraemer M, Seow-Choen F, et al. High ­pre-operative serum cancinoembryonic antigen predicts metastatic recurrence in potentially curative colonic ­cancer: results of a five-year study. Dis Colon Rectum. 2001;44:231–5.CrossRefGoogle Scholar
  36. 36.
    Moertel CG, Fleming TR, Mac Donald JS, et al. An evaluation of the carcinoembryonic antigen (CEA) for monitoring patients with resected colon cancer. JAMA. 1993;270:943–7.CrossRefGoogle Scholar
  37. 37.
    The Standards Practice Task Force, The American Society of Colon and Rectal Surgeons. Practice parameters for the surveillance and follow up of patients with colon and rectal cancer. Dis Colon Rectum. 2004;47:807–17.CrossRefGoogle Scholar
  38. 38.
    Paramo JC, Summerall J, Poppiti R, Mesko TW. Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol. 2002;9:550–4.CrossRefGoogle Scholar
  39. 39.
    Fazio VW, Kirian RP. Surgical treatment of colon cancer: does sentinel node technology have a role? Adv Surg. 2003;37:71–94.PubMedGoogle Scholar
  40. 40.
    Scott NA, Rainwater LM, Weiand HS, et al. The relative prognostic value of flow cytometric DNA analysis and conventional clinicopathologic criteria in patients with operable cancer. Dis Colon Rectum. 1987;30:513–20.CrossRefGoogle Scholar
  41. 41.
    Hughes TG, Jenevein EP, Poulos E. Intramural spread of colon carcinoma. A pathologic study. Am J Surg. 1983;146:697–9.CrossRefGoogle Scholar
  42. 42.
    Nelson H, Petrelli N, Carlin A, et al. Guidelines 2000 for colon and rectal cancer surgery. J Natl Cancer Inst. 2001;93:583–96.CrossRefGoogle Scholar
  43. 43.
    de Haas-kock DF, Baeten CG, Jager JJ, et al. Prognostic significance of radial margins of clearance in rectal cancer. Br J Surg. 1996;83:781–5.CrossRefGoogle Scholar
  44. 44.
    Tominaga T, Sakabe T, Koyama Y, et al. Prognostic factors for patients with colon or rectal carcinoma treated with resection only. Five-year follow-up report. Cancer. 1996;78:403–8.CrossRefGoogle Scholar
  45. 45.
    Wright JD, Powell MA, Mutch DG, et al. Synchronous ovarian metastases at the time of laparotomy for colon cancer. Gynecol Oncol. 2004;92:851–5.CrossRefGoogle Scholar
  46. 46.
    Chong A, Shah JN, Levine MS, et al. Diagnostic yield of barium enema examination after incomplete colonoscopy. Radiology. 2002;223:620–4.CrossRefGoogle Scholar
  47. 47.
    Neri E, Giusti P, Battolla L, et al. Colorectal cancer: role of CT colonography in the preoperative evaluation after incomplete colonoscopy. Radiology. 2002;223:615–9.CrossRefGoogle Scholar
  48. 48.
    Alderson PO, Adams DF, McNeil BJ, et al. Computed tomography, ultrasound, and scintigraphy of the liver in patients with colon or breast carcinoma: a prospective comparison. Radiology. 1983;149:225–30.CrossRefGoogle Scholar
  49. 49.
    Nagata K, Ota Y, Okawa T, Endo S, et al. PET/CT colonography for the preoperative evaluation of the colon proximal to the obstructive colorectal cancer. Dis Colon Rectum. 2008;51(6):882–90.CrossRefGoogle Scholar
  50. 50.
    Glover C, Douse P, Kane P, et al. Accuracy of investigations for asymptomatic colorectal liver metastases. Dis Colon Rectum. 2002;45:476–84.CrossRefGoogle Scholar
  51. 51.
    Pihl E, Hughes ES, McDermott FT, et al. Lung recurrence after curative surgery for colorectal cancer. Dis Colon Rectum. 1987;30:417–9.CrossRefGoogle Scholar
  52. 52.
    Allegra CJ, Jessup M, Somerfield MR, Hamilton SR, et al. American Society of Clinical Oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol. 2009;27(12):2091–96.CrossRefGoogle Scholar
  53. 53.
    Bipat S, van Leeuwen MS, Comans EFI, Pilil ME, et al. Colorectal liver metastases A: CT, MR imaging, and PET for diagnosis – meta-analysis. Radiology. 2005;237(1):123–31.CrossRefGoogle Scholar
  54. 54.
    Siena S, Sartore-Bianchi A, Di Nicolantonio F, Balfour J, et al. Review: biomarkers predicting clinical outcome of epidermal growth factor receptor-targeted therapy in metastatic colorectal cancer. J Natl Cancer Inst. 2009;101(19):1308–24.CrossRefGoogle Scholar
  55. 55.
    Mutch MG. Molecular profiling and risk stratification of adenocarcinoma of the colon. J Surg Oncol. 2007;96(8):693–703.CrossRefGoogle Scholar

Copyright information

© ASCRS (American Society of Colon and Rectal Surgeons) 2011

Authors and Affiliations

  • Eric G. Weiss
    • 1
  1. 1.Cleveland Clinic FloridaWestonUSA

Personalised recommendations